ANDA 81310, held by ANI Pharmaceuticals. Fluphenazine Hydrochloride.
As of Nov 21, 2026, ANDA 81310 (Fluphenazine Hydrochloride), held by ANI Pharmaceuticals, was first approved by FDA on Apr 29, 1993, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 29, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fluphenazine Hydrochloride2.5MG/5ML · elixir;oral | Fluphenazine Hydrochloride | Discontinued |
| Mar 23, 1999 | Supplement 5Manufacturing | Approved | None posted |
| Jun 11, 1998 | Supplement 4Manufacturing | Approved | None posted |
| May 31, 1996 | Supplement 3Manufacturing | Approved | None posted |
| May 9, 1995 | Supplement 2Manufacturing | Approved | None posted |
| Dec 12, 1994 | Supplement 1Manufacturing | Approved | None posted |
| Apr 29, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters